Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Account Payables (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Change in Account Payables for 15 consecutive years, with -$317504.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables fell 157.64% year-over-year to -$317504.0, compared with a TTM value of -$161567.0 through Sep 2025, up 74.7%, and an annual FY2024 reading of -$424318.0, down 179.85% over the prior year.
  • Change in Account Payables was -$317504.0 for Q3 2025 at Sanara MedTech, up from -$638300.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $923707.0 in Q3 2023 and bottomed at -$1.1 million in Q3 2022.
  • Average Change in Account Payables over 5 years is -$20419.4, with a median of $9071.0 recorded in 2021.
  • Peak annual rise in Change in Account Payables hit 5315.28% in 2022, while the deepest fall reached 14106.14% in 2022.
  • Year by year, Change in Account Payables stood at $116763.0 in 2021, then skyrocketed by 327.21% to $498822.0 in 2022, then plummeted by 103.17% to -$15806.0 in 2023, then surged by 1355.23% to $198401.0 in 2024, then crashed by 260.03% to -$317504.0 in 2025.
  • Business Quant data shows Change in Account Payables for SMTI at -$317504.0 in Q3 2025, -$638300.0 in Q2 2025, and $595836.0 in Q1 2025.